Full-Time

Commercial Project Manager Isoflex™ Active

Posted on 10/31/2025

FMC Corporation

FMC Corporation

5,001-10,000 employees

Develops herbicides, insecticides, and fungicides

No salary listed

Frankfurt, Germany

Hybrid

Category
Business & Strategy (1)
Requirements
  • University degree in Business, Agriculture, Life Sciences, or related field; advanced degree or MBA is a plus is a plus?
  • Experience in project management with strong exposure to commercial or product launch activities, ideally in agrochemicals, life sciences, or agriculture
  • Proven ability to manage complex, cross-functional projects with a business-driven mindset
  • Strong commercial acumen and ability to align project execution with strategic goals
  • Excellent communication, coordination, and stakeholder management skills
  • Fluent in German and English
  • Proficient in MS Office and project management tools
  • Based in Frankfurt, with willingness to travel within the country
Responsibilities
  • Lead the end-to-end project management of the Isoflex™ active launch in Germany, ensuring all milestones are achieved on time and in line with business goals
  • Ensure commercial priorities—such as pricing, positioning, target segments, and competitive differentiation—are embedded in all project workstreams
  • Build and manage a detailed project plan with clear timelines, responsibilities, and deliverables
  • Act as the main point of contact for all launch-related activities within Germany
  • Align and coordinate efforts across marketing, sales, regulatory, supply chain, development, and technical support teams
  • Organize and moderate regular project meetings; ensure clarity of roles, responsibilities, and progress tracking
  • Collaborate closely with the commercial and marketing teams to ensure readiness for sales activation and customer engagement
  • Prepare and present regular status updates, dashboards, and decision materials for senior stakeholders
  • Maintain clear documentation of project scope, decisions, risks, and next steps
  • Escalate critical issues and ensure timely resolution of cross-functional challenges
  • Ensure all commercial deliverables are in place ahead of launch, including pricing strategies, marketing materials, sales tools, supply readiness, and regulatory approvals
  • Monitor progress against key launch KPIs and ensure alignment with commercial expectations
  • Coordinate internal training sessions and go-to-market rollouts in collaboration with the sales team
Desired Qualifications
  • Advanced degree or MBA is a plus
  • Experience in agrochemicals, life sciences, or agriculture is desirable
  • Experience with project management tools beyond MS Office (e.g., specialized PM software) is desirable

FMC Corporation focuses on improving agriculture through science-based solutions. It develops and provides herbicides, insecticides, and fungicides, along with product formulations and technologies, to protect crops from pests and diseases while aiming to minimize environmental impact. The way FMC’s products work is by delivering active ingredients through formulations that enhance efficacy and safety, helping farmers protect yields and manage pests in a sustainable way. What sets FMC apart is its long history and explicit commitment to sustainable technologies and environmental protection, along with ongoing research to discover new active ingredients and smarter formulations. The company's overarching goal is to help farmers feed a growing global population by delivering science-driven agricultural solutions that safeguard crops and protect the planet.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Philadelphia, Pennsylvania

Founded

1883

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 adjusted EBITDA hit $72M, beating guidance high-end.
  • $252M India divestiture to Crystal Crop closes by year-end 2026, cuts debt.
  • Project Foundation shifts production to low-cost sites, boosting margins.

What critics are saying

  • Cortevia undercuts Isoflex in Europe, capturing 30% share in 12-18 months.
  • Tighter credit covenants breach on 5x leverage, forcing asset sales in 6-12 months.
  • Indian regulators block $252M sale by year-end 2026 over security concerns.

What makes FMC Corporation unique

  • FMC's three newest active ingredients generated $200M sales in 2025, up 54% YoY.
  • Isoflex active ingredient gained EU approval on April 6, 2026, for European crops.
  • Strategic investment in AgroSpheres on November 27, 2023, accesses sustainable crop tech.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Family Planning Benefits

Mental Health Support

Company News

Yahoo Finance
Mar 31st, 2026
FMC Corp shares jump 6.66% ahead of $0.08 dividend and Q1 earnings amid revenue decline forecast

FMC Corporation shares climbed 6.66% on Monday to close at $16.81, extending its winning streak to seven consecutive days. The rally came as investors positioned ahead of the company's dividend cutoff date and upcoming earnings release. FMC will distribute 8 cents per share to shareholders of record as of 31st March, payable on 16th April. The company is scheduled to report first-quarter results after market close on 29th April. For the first quarter, FMC expects revenues of $725 million to $775 million, excluding India operations, representing a 5% year-on-year decline. Adjusted EBITDA is forecast at $45 million to $55 million, down 54% to 62.5% from the prior year. For full-year 2026, the company targets revenues of $3.6 billion to $3.8 billion, with adjusted EBITDA of $670 million to $730 million.

Yahoo Finance
Feb 7th, 2026
FMC Corporation: Deep-value play emerges after 83% dividend cut amid agricultural headwinds

FMC Corporation, an agricultural sciences company, has emerged as a potential deep-value opportunity following an 83% dividend cut and severe sell-off driven by agricultural demand weakness and pricing pressures. Trading at $16.02 with a forward P/E of 7.18, the stock reflects significant market pessimism. Despite third-quarter 2025 revenue declining materially, adjusted earnings improved year-over-year through cost controls and favourable product mix. However, the company faces substantial balance sheet risk with approximately $4.5 billion in debt against expected EBITDA of $850 million, pushing leverage above 5×. Management is prioritising debt reduction through potential divestitures, including its India business, whilst maintaining investment in new active ingredients and biological products. The investment case depends on agricultural cycle recovery and successful deleveraging execution. Hedge fund ownership declined from 43 to 35 funds in the third quarter.

AgFunderNews
Oct 1st, 2024
Brief: Agrospheres lands additional Series B funding to 'take a giant leap forward' in bringing biopesticides to market

Funding will help further build out the Agrospheres platform, which manufactures, encapsulates and delivers biological pesticides.

Business Wire
Jul 26th, 2024
Micropep Raises $29M in Series B Funding and Unveils Krisalix, its Proprietary Discovery Platform

Micropep Technologies (Micropep), the global leader in micropeptide technology, today announced a $29 million Series B funding round along with its pr

AgroSpheres
Dec 1st, 2023
AgroSpheres

CHARLOTTESVILLE, Va. November 27, 2023 – AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection, today announced the closing of its Series B funding round with a strategic investment from FMC Corporation (NYSE: FMC), a global leader in agriculture sciences. This investment brings the total funding in AgroSpheres’ Series B round to $25 million, demonstrating the strong confidence in the company’s innovative solutions. FMC Ventures joins Lewis and Clark AgriFood, Ospraie Ag Science, BIDRA Ventures, and Cavallo Ventures to close out the round.

INACTIVE